PortfoliosLab logoPortfoliosLab logo
PRLD vs. NIC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PRLD vs. NIC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Prelude Therapeutics Incorporated (PRLD) and Nicolet Bankshares Inc. (NIC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PRLD achieves a 51.38% return, which is significantly higher than NIC's 43.71% return.


PRLD

1D
-4.57%
1M
-10.59%
6M
116.26%
YTD
51.38%
1Y
430.00%
3Y*
6.15%
5Y*
-32.60%
10Y*
ALL TIME*
-25.83%

NIC

1D
1.52%
1M
4.07%
6M
17.35%
YTD
43.71%
1Y
39.06%
3Y*
28.88%
5Y*
20.27%
10Y*
17.27%
ALL TIME*
17.81%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$36.20M$36.21M$43.17M
$1.90M$1.67M$1.93M

PRLD vs. NIC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
PRLD
Prelude Therapeutics Incorporated
51.38%127.45%-70.14%-29.30%-51.49%-82.60%183.59%
NIC
Nicolet Bankshares Inc.
43.71%16.76%31.91%1.93%-6.95%29.24%22.92%

Correlation

The correlation between PRLD and NIC is 0.09, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.09

Correlation (3Y)
Balances recent behavior with more history.

0.20

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.20

Correlation (All Time)
Calculated using the full available price history since Sep 25, 2020

0.18

The correlation between PRLD and NIC shifts across timeframes, from 0.09 (1 year) to 0.20 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

PRLD:

$249.93M

NIC:

$3.00B

EPS

PRLD:

-$1.05

NIC:

$13.46

PS Ratio

PRLD:

19.39

NIC:

3.39

Total Revenue (TTM)

PRLD:

$16.72M

NIC:

$586.41M

Gross Profit (TTM)

PRLD:

$11.30M

NIC:

$248.69M

EBITDA (TTM)

PRLD:

-$82.17M

NIC:

$260.57M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Prelude Therapeutics Incorporated

Nicolet Bankshares Inc.

Return for Risk

PRLD vs. NIC — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

PRLD
PRLD Risk / Return Rank: 9595
Overall Rank
PRLD Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
PRLD Sortino Ratio Rank: 9595
Sortino Ratio Rank
PRLD Omega Ratio Rank: 9696
Omega Ratio Rank
PRLD Calmar Ratio Rank: 9797
Calmar Ratio Rank
PRLD Martin Ratio Rank: 9595
Martin Ratio Rank

NIC
NIC Risk / Return Rank: 7878
Overall Rank
NIC Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
NIC Sortino Ratio Rank: 7676
Sortino Ratio Rank
NIC Omega Ratio Rank: 7575
Omega Ratio Rank
NIC Calmar Ratio Rank: 8080
Calmar Ratio Rank
NIC Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

PRLD vs. NIC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Prelude Therapeutics Incorporated (PRLD) and Nicolet Bankshares Inc. (NIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PRLDNICDifference
Sharpe ratioReturn per unit of total volatility

+0.89

Sortino ratioReturn per unit of downside risk

+1.73

Omega ratioGain probability vs. loss probability

1.51

1.23

+0.28

Calmar ratioReturn relative to maximum drawdown

6.18

2.19

+3.99

Martin ratioReturn relative to average drawdown

13.70

5.12

+8.58

PRLD vs. NIC - Sharpe Ratio Comparison

The current PRLD Sharpe Ratio is 2.17, which is higher than the NIC Sharpe Ratio of 1.28. The chart below compares the historical Sharpe Ratios of PRLD and NIC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PRLD vs. NIC - Drawdown Comparison

The maximum PRLD drawdown since its inception was -99.33%, which is greater than NIC's maximum drawdown of -44.31%. Use the drawdown chart below to compare losses from any high point for PRLD and NIC.


Loading charts...

Drawdown Indicators


PRLDNICDifference

Max Drawdown

Largest peak-to-trough decline

-99.33%

-44.31%

-55.02%

Max Drawdown (1Y)

Largest decline over 1 year

-70.10%

-17.90%

-52.20%

Max Drawdown (3Y)

Largest decline over 3 years

-90.42%

-21.73%

-68.69%

Max Drawdown (5Y)

Largest decline over 5 years

-98.42%

-44.31%

-54.11%

Max Drawdown (10Y)

Largest decline over 10 years

-44.31%

Current Drawdown

Current decline from peak

-95.21%

0.00%

-95.21%

Average Drawdown

Average peak-to-trough decline

-85.39%

-11.07%

-74.32%

Ulcer Index

Depth and duration of drawdowns from previous peaks

31.57%

7.65%

+23.92%

Volatility

PRLD vs. NIC - Volatility Comparison

Prelude Therapeutics Incorporated (PRLD) has a higher volatility of 25.84% compared to Nicolet Bankshares Inc. (NIC) at 6.54%. This indicates that PRLD's price experiences larger fluctuations and is considered to be riskier than NIC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PRLDNICDifference

Volatility (1M)

Calculated over the trailing 1-month period

25.84%

6.54%

+19.30%

Volatility (6M)

Calculated over the trailing 6-month period

78.30%

21.03%

+57.27%

Volatility (1Y)

Calculated over the trailing 1-year period

200.19%

30.64%

+169.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

125.66%

30.49%

+95.17%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

121.39%

30.80%

+90.59%

Dividends

PRLD vs. NIC - Dividend Comparison

PRLD has not paid dividends to shareholders, while NIC's dividend yield for the trailing twelve months is around 0.76%.


PositionTTM202520242023
NIC
Nicolet Bankshares Inc.
0.76%1.02%1.04%0.93%
PRLD
Prelude Therapeutics Incorporated
0.00%0.00%0.00%0.00%

Financials

PRLD vs. NIC - Financials Comparison

This section allows you to compare key financial metrics between Prelude Therapeutics Incorporated and Nicolet Bankshares Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


PRLD and NIC have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PRLD has higher volatility (25.84%) compared to NIC (6.54%). In terms of maximum drawdown, PRLD dropped -99.33% vs NIC's -44.31%.

PRLD currently has the higher Sharpe Ratio (2.17 vs 1.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PRLD and NIC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer